Steven Sweeney

Safety and efficacy of LY2951742, a monoclonal antibody to calcitonin gene-related peptide, for the prevention of migraine: a phase 2, randomised, double-blind, placebo-controlled study

David W. Dodick, Peter J. Goadsby, Egilius L.H. Spierings et al. · The Lancet Neurology · 2014 · 365 citations

Pharmacy, Pharmacology, Pharmacotherapy +13

In vivo tau pathology is associated with synaptic loss and altered synaptic function

Emma M. Coomans, Deborah N. Schoonhoven, Hayel Tuncel et al. · Alzheimer s Research & Therapy · 2021 · 105 citations · Full text

Life Sciences, Neurology, Neuroscience +17

Kinetics and 28-day test–retest repeatability and reproducibility of [ ¹¹ C]UCB-J PET brain imaging

Hayel Tuncel, Ronald Boellaard, Emma M. Coomans et al. · Journal of Cerebral Blood Flow & Metabolism · 2020 · 68 citations · Full text

Medicine, Neuroscience, Nuclear Medicine +17

Safety and clinical effect of i.v. infusion of cyclopropyl-methoxycarbonyl etomidate (ABP-700), a soft analogue of etomidate, in healthy subjects

Beatrijs I. Valk, Anthony Absalom, P Meyer et al. · British Journal of Anaesthesia · 2018 · 40 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacology +9

A Phase 1, Single-center, Double-blind, Placebo-controlled Study in Healthy Subjects to Assess the Safety, Tolerability, Clinical Effects, and Pharmacokinetics–Pharmacodynamics of Intravenous Cyclopropyl-methoxycarbonylmetomidate (ABP-700) after a Single Ascending Bolus Dose

Michel Struys, Beatrijs I. Valk, Douglas J. Eleveld et al. · Anesthesiology · 2017 · 38 citations

Pharmacy, Pharmacokinetics, Pharmacology +13